She still has confidence that the vaccination will certainly get to the marketplace.
发布者：BY ANJA HAUGE，转转请注明出处：https://robotalks.cn/ceo-of-danish-cancer-vaccine-developer-remains-confident-despite-disappointing-phase-3-study/
CEO of Danish cancer vaccine developer remains confident despite disappointing phase 3 study
赞 (0)
关于作者
Zealand Pharma CEO: Expectations for the obesity market need to be adjusted
上一篇
20 8 月, 2025 4:18 上午
Zealand Pharma CEO plans to use bulging coffers to secure launch of crown jewel
下一篇
20 8 月, 2025 4:18 上午
相关推荐
-
CeMAT Southeast Asia & LogiSYM Asia Pacific 2025: Robotics Drive Forward as Supply Chains Strategize
Bob Gill, General Supervisor of ARC Advisory Team (ideal), offered the honor to Dave Ching, Head of Sales for Southeast Asia, Australia, and New Zealand (left). From Might 19 to 21…
-
eVTOL Leader Lilium’s Tom Brassington Joins Horizon Aircraft
Perspective Airplane, a cutting-edge aerospace design business concentrating on eVTOL modern technology, has actually revealed the consultation of Tom Brassington as its brand-new …
-
Fantom Price Prediction: FTM price Soars 60%, Eyes To Hit $1?
The message Fantom Cost Forecast: FTM rate Rises 60%, Eyes To Strike $1? showed up initially on Coinpedia Fintech InformationAfter trading under an extreme bearish belief for a qui…
-
Orano’s uranium joint venture in Niger on brink of bankruptcy
French uranium mining business, Orano, has actually supposedly introduced that its joint endeavor with Niger, SOMAIR, is dealing with insolvency. The article Orano’s uranium joint …
-
OpenThruster: An open-source, mostly 3D-printed thruster for marine vehicles
Thrusters are essential components of marine robotic vehicles for surface or underwater use. However, their high cost often makes them inaccessible to hobbyists, early-career resea…
